Florian Guisier

3.7k total citations
102 papers, 1.2k citations indexed

About

Florian Guisier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Florian Guisier has authored 102 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Pulmonary and Respiratory Medicine, 67 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Florian Guisier's work include Lung Cancer Treatments and Mutations (67 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Research Studies (30 papers). Florian Guisier is often cited by papers focused on Lung Cancer Treatments and Mutations (67 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Research Studies (30 papers). Florian Guisier collaborates with scholars based in France, United States and Réunion. Florian Guisier's co-authors include Mathieu Salaün, C. Chouaïd, Luc Thiberville, Nicolas Piton, Olivier Bylicki, M. Pérol, J.B. Auliac, H. Doubre, L. Falchero and Jean‐Marc Baste and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Florian Guisier

92 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Guisier France 19 901 718 247 216 94 102 1.2k
Masahiro Morise Japan 17 752 0.8× 707 1.0× 206 0.8× 141 0.7× 124 1.3× 112 1.1k
Kaname Nosaki Japan 19 913 1.0× 976 1.4× 366 1.5× 256 1.2× 80 0.9× 91 1.4k
Ryo Toyozawa Japan 17 629 0.7× 618 0.9× 182 0.7× 105 0.5× 66 0.7× 89 932
Motohiro Tamiya Japan 23 1.3k 1.4× 1.2k 1.7× 317 1.3× 189 0.9× 149 1.6× 163 1.9k
Yuichi Sakamori Japan 19 932 1.0× 1.0k 1.4× 330 1.3× 146 0.7× 59 0.6× 81 1.5k
Jin‐Hyuk Choi South Korea 18 483 0.5× 488 0.7× 318 1.3× 147 0.7× 126 1.3× 73 944
Filippo Gustavo Dall’Olio Italy 13 433 0.5× 610 0.8× 178 0.7× 229 1.1× 127 1.4× 39 956
Reyes Bernabé Spain 19 611 0.7× 684 1.0× 211 0.9× 173 0.8× 67 0.7× 92 1.1k
Michihiko Tajiri Japan 20 600 0.7× 348 0.5× 352 1.4× 203 0.9× 140 1.5× 72 1.1k

Countries citing papers authored by Florian Guisier

Since Specialization
Citations

This map shows the geographic impact of Florian Guisier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Guisier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Guisier more than expected).

Fields of papers citing papers by Florian Guisier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Guisier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Guisier. The network helps show where Florian Guisier may publish in the future.

Co-authorship network of co-authors of Florian Guisier

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Guisier. A scholar is included among the top collaborators of Florian Guisier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Guisier. Florian Guisier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greillier, Laurent, Florian Guisier, Catherine Daniel, et al.. (2025). Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study. Lung Cancer. 209. 108766–108766.
2.
Guisier, Florian, Pernelle Lavaud, Laurent Greillier, et al.. (2024). Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study. ESMO Open. 9(12). 103968–103968. 2 indexed citations
3.
4.
5.
Lachkar, Samy, et al.. (2024). Direct endoscopic visualization of small peripheral lung nodules using a miniaturized videoendoscopy probe. Respirology. 29(10). 914–917. 2 indexed citations
6.
Guisier, Florian, Charles Ricordel, Seyyid Baloglu, et al.. (2024). Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort. Current Oncology. 31(3). 1656–1666. 2 indexed citations
7.
Lachkar, Samy, et al.. (2023). Place de l’endoscopie dans les gestions des nodules périphériques. Partie 1 : diagnostic. Revue des Maladies Respiratoires. 40(9-10). 810–819.
8.
Decazes, Pierre, Samy Ammari, Hugues Talbot, et al.. (2023). Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer. Journal for ImmunoTherapy of Cancer. 11(9). e007315–e007315. 9 indexed citations
9.
Vergnenègre, A., I. Monnet, Charles Ricordel, et al.. (2023). Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo). Lung Cancer. 178. 191–197. 5 indexed citations
10.
Lachkar, Samy, Florent Marguet, Liana Veresezan, et al.. (2023). Assessment of endobronchial ultrasound‐guided bronchoscopy (EBUS) intranodal forceps biopsy added to EBUS 19‐gauge transbronchial needle aspiration: A blinded pathology panel analysis. Thoracic Cancer. 14(22). 2149–2157. 6 indexed citations
11.
Lachkar, Samy, Pierre‐Alain Thiébaut, Florent Marguet, et al.. (2023). Detection of Tumor DNA in Bronchoscopic Fluids in Peripheral NSCLC: A Proof-of-Concept Study. JTO Clinical and Research Reports. 5(2). 100596–100596. 1 indexed citations
12.
Piton, Nicolas, et al.. (2023). Beyond the Frontline: A Triple-Line Approach of Thoracic Surgeons in Lung Cancer Management—State of the Art. Cancers. 15(16). 4039–4039. 3 indexed citations
13.
Ekman, Simon, Florian Guisier, Cheryl Ho, et al.. (2023). 1381P TOGETHER: Pooled real-world datasets of METex14 skipping NSCLC and adjusted comparison of upfront (chemo-)immunotherapy with tepotinib from VISION. Annals of Oncology. 34. S792–S793. 3 indexed citations
14.
Jamme, Philippe, Jean‐Baptiste Assié, Rémi Veillon, et al.. (2023). Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study. Targeted Oncology. 18(4). 585–591. 3 indexed citations
15.
16.
Pîrlog, Radu, Nicolas Piton, Aude Lamy, et al.. (2022). Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas. Cancers. 14(4). 1030–1030. 10 indexed citations
17.
Lachkar, Samy, Mathieu Salaün, M. Marchi, et al.. (2021). Virtual Bronchoscopy Planner and Radial-EBUS Guided Biopsy for Organizing Pneumonia Diagnosis. Journal of Clinical Medicine. 11(1). 104–104. 1 indexed citations
18.
Piton, Nicolas, et al.. (2021). Lung Cancer Surgery after Treatment with Anti-PD1/PD-L1 Immunotherapy for Non-Small-Cell Lung Cancer: A Case—Cohort Study. Cancers. 13(19). 4915–4915. 9 indexed citations
19.
Piton, Nicolas, et al.. (2021). Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations. International Journal of Molecular Sciences. 22(12). 6288–6288. 93 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masahiro Morise Breakdown of academic impact, for papers by Kaname Nosaki Breakdown of academic impact, for papers by Ryo Toyozawa Breakdown of academic impact, for papers by Motohiro Tamiya Breakdown of academic impact, for papers by Yuichi Sakamori Breakdown of academic impact, for papers by Jin‐Hyuk Choi Breakdown of academic impact, for papers by Filippo Gustavo Dall’Olio Breakdown of academic impact, for papers by Reyes Bernabé Breakdown of academic impact, for papers by Michihiko Tajiri
Rankless by CCL
2026